DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 1 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,260,062 | -40.3% | 875,993 | 0.0% | 0.12% | -42.4% |
| Q2 2023 | $3,784,290 | +184.8% | 875,993 | +0.9% | 0.20% | +156.2% |
| Q1 2023 | $1,328,672 | +3.5% | 868,413 | +6.9% | 0.08% | 0.0% |
| Q4 2022 | $1,283,844 | +27.4% | 812,508 | 0.0% | 0.08% | +12.7% |
| Q3 2022 | $1,007,510 | -38.6% | 812,508 | 0.0% | 0.07% | -37.2% |
| Q2 2022 | $1,641,266 | -19.2% | 812,508 | 0.0% | 0.11% | +5.6% |
| Q1 2022 | $2,031,270 | +81.5% | 812,508 | +170.8% | 0.11% | +91.1% |
| Q4 2021 | $1,119,000 | +39.5% | 300,000 | +50.0% | 0.06% | +30.2% |
| Q3 2021 | $802,000 | +259.6% | 200,000 | +300.0% | 0.04% | +230.8% |
| Q2 2021 | $223,000 | -51.3% | 50,000 | 0.0% | 0.01% | -55.2% |
| Q1 2021 | $458,000 | +50.7% | 50,000 | +66.7% | 0.03% | +31.8% |
| Q4 2020 | $304,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,146,470 | $4,861,000 | 5.06% |
| Corriente Advisors, LLC | 730,000 | $3,095,000 | 1.57% |
| Manatuck Hill Partners, LLC | 571,500 | $2,423,000 | 1.11% |
| CVI Holdings, LLC | 276,176 | $1,171,000 | 0.48% |
| DAFNA Capital Management LLC | 156,529 | $664,000 | 0.22% |
| Worth Venture Partners, LLC | 42,887 | $182,000 | 0.15% |
| Granite Point Capital Management, L.P. | 646,855 | $2,743,000 | 0.15% |
| Ikarian Capital, LLC | 415,000 | $1,759,000 | 0.13% |
| Maven Securities LTD | 359,285 | $1,473,000 | 0.12% |
| Nantahala Capital Management | 756,193 | $3,206,000 | 0.10% |